Methodological aspects of 99mTc-sestamibi guided biopsy in breast cancer.
A CollarinoR A Valdés OlmosA F van der HoevenLenka M Pereira Arias BoudaPublished in: Clinical and translational imaging (2016)
MBI-guided biopsy appears to be a complementary modality and is principally indicated in the case of occult or unclear breast lesions on MG/US, that are suspicious on MBI. The future indication is in targeted biopsies in patients with large heterogeneous tumours. Further studies are needed to define the accuracy of this biopsy procedure.